Targeting immune checkpoints in hepatocellular carcinoma therapy: toward combination strategies with curative potential

Abstract Hepatocellular carcinoma (HCC) is a primary liver cancer characterized by poor immune cell infiltration and a strongly immunosuppressive microenvironment. Traditional treatments have often yielded unsatisfactory outcomes due to the insidious onset of the disease. Encouragingly, the introduc...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Jing Tong, Yongci Tan, Wenwen Ouyang, Haocai Chang
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2025-05-01
Σειρά:	Experimental Hematology & Oncology
Θέματα:	Hepatocellular carcinoma Immune checkpoint inhibitors ICI monotherapy Dual ICI therapy ICI-based combination therapy
Διαθέσιμο Online:	https://doi.org/10.1186/s40164-025-00636-5
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!